Mizuho Securities USA’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Mizuho Securities USA’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$500K	–	252
2022 Q3	$500K	Buy	+50,000	New	+$496K	0.07%	163

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Mizuho Securities USA's PKBO Position: Q4 2022 in Review

Mizuho Securities USA sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 50,000 shares — an estimated $500K sold.

Mizuho Securities USA first reported a position in PKBO in Q3 2022 and held it in 1 quarter. The position peaked at $500K in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Mizuho Securities USA reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Mizuho Securities USA sold 50,000 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $500K.
Mizuho Securities USA first reported a position in Peak Bio, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Mizuho Securities USA's Peak Bio, Inc. Common Stock position peaked at $500K in Q3 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Mizuho Securities USA's 13F filing for Q4 2022, filed 3 Feb 2023.